124 related articles for article (PubMed ID: 9641003)
21. Effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of alprazolam.
Yasui N; Kondo T; Otani K; Furukori H; Kaneko S; Ohkubo T; Nagasaki T; Sugawara K
Psychopharmacology (Berl); 1998 Oct; 139(3):269-73. PubMed ID: 9784084
[TBL] [Abstract][Full Text] [Related]
22. Coadministration of nefazodone and benzodiazepines: III. A pharmacokinetic interaction study with alprazolam.
Greene DS; Salazar DE; Dockens RC; Kroboth P; Barbhaiya RH
J Clin Psychopharmacol; 1995 Dec; 15(6):399-408. PubMed ID: 8748428
[TBL] [Abstract][Full Text] [Related]
23. Comparison of the pharmacokinetics of venlafaxine extended release and desvenlafaxine in extensive and poor cytochrome P450 2D6 metabolizers.
Preskorn S; Patroneva A; Silman H; Jiang Q; Isler JA; Burczynski ME; Ahmed S; Paul J; Nichols AI
J Clin Psychopharmacol; 2009 Feb; 29(1):39-43. PubMed ID: 19142106
[TBL] [Abstract][Full Text] [Related]
24. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
[TBL] [Abstract][Full Text] [Related]
25. Alprazolam as a probe for CYP3A using a single blood sample: pharmacokinetics of parent drug, and of alpha- and 4-hydroxy metabolites in healthy subjects.
Wennerholm A; Allqvist A; Svensson JO; Gustafsson LL; Mirghani RA; Bertilsson L
Eur J Clin Pharmacol; 2005 Apr; 61(2):113-8. PubMed ID: 15806426
[TBL] [Abstract][Full Text] [Related]
26. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
[TBL] [Abstract][Full Text] [Related]
27. Lack of effect of sertraline on the pharmacokinetics of alprazolam.
Preskorn SH; Greenblatt DJ; Harvey AT
J Clin Psychopharmacol; 2000 Oct; 20(5):585-6. PubMed ID: 11001249
[No Abstract] [Full Text] [Related]
28. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
[TBL] [Abstract][Full Text] [Related]
29. Dose-response evaluation of the interaction between sertraline and alprazolam in vivo.
Hassan PC; Sproule BA; Naranjo CA; Herrmann N
J Clin Psychopharmacol; 2000 Apr; 20(2):150-8. PubMed ID: 10770452
[TBL] [Abstract][Full Text] [Related]
30. Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
DeVane CL; Donovan JL; Liston HL; Markowitz JS; Cheng KT; Risch SC; Willard L
J Clin Psychopharmacol; 2004 Feb; 24(1):4-10. PubMed ID: 14709940
[TBL] [Abstract][Full Text] [Related]
31. Alprazolam-ritonavir interaction: implications for product labeling.
Greenblatt DJ; von Moltke LL; Harmatz JS; Durol AL; Daily JP; Graf JA; Mertzanis P; Hoffman JL; Shader RI
Clin Pharmacol Ther; 2000 Apr; 67(4):335-41. PubMed ID: 10801241
[TBL] [Abstract][Full Text] [Related]
32. Maternal use of venlafaxine near term: correlation between neonatal effects and plasma concentrations.
Boucher N; Koren G; Beaulac-Baillargeon L
Ther Drug Monit; 2009 Jun; 31(3):404-9. PubMed ID: 19455083
[TBL] [Abstract][Full Text] [Related]
33. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
[TBL] [Abstract][Full Text] [Related]
34. Kinetics and dynamics of intravenous adinazolam, N-desmethyl adinazolam, and alprazolam in healthy volunteers.
Venkatakrishnan K; Culm KE; Ehrenberg BL; Harmatz JS; Corbett KE; Fleishaker JC; Greenblatt DJ
J Clin Pharmacol; 2005 May; 45(5):529-37. PubMed ID: 15831776
[TBL] [Abstract][Full Text] [Related]
35. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
36. Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.
Molanaei H; Stenvinkel P; Qureshi AR; Carrero JJ; Heimbürger O; Lindholm B; Diczfalusy U; Odar-Cederlöf I; Bertilsson L
Eur J Clin Pharmacol; 2012 May; 68(5):571-7. PubMed ID: 22159869
[TBL] [Abstract][Full Text] [Related]
37. Abrupt discontinuation of alprazolam and cognitive style in patients with panic disorder: early effects on mood, performance, and vital signs.
Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
J Clin Psychopharmacol; 2006 Oct; 26(5):519-23. PubMed ID: 16974197
[TBL] [Abstract][Full Text] [Related]
38. Alprazolam pharmacokinetics, metabolism, and plasma levels: clinical implications.
Greenblatt DJ; von Moltke LL; Harmatz JS; Ciraulo DA; Shader RI
J Clin Psychiatry; 1993 Oct; 54 Suppl():4-11; discussion 12-4. PubMed ID: 8262889
[TBL] [Abstract][Full Text] [Related]
39. Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers.
Wong SL; Locke C; Staser J; Granneman GR
Psychopharmacology (Berl); 1998 Feb; 135(3):236-41. PubMed ID: 9498726
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous quantification of alprazolam, 4- and alpha-hydroxyalprazolam in plasma samples using liquid chromatography mass spectrometry.
Allqvist A; Wennerholm A; Svensson JO; Mirghani RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):127-31. PubMed ID: 15607716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
